Literature DB >> 20358712

NO-Xplode: a case of supplement-associated ischemic colitis.

Charles D Magee1, Fouad J Moawad, Frank Moses.   

Abstract

The most common cause of ischemic colitis (IC) is a sudden and transient reduction in splanchnic perfusion. In the younger population, medications are an increasingly recognized cause of ischemic bowel disease. Over-the-counter supplements may also lead to the development of ischemic colitis through similar effects. We present a case of ischemic colitis in a 42-year-old active duty service member after using the performance-enhancing supplement, NO-Xplode. In this report, we review the pharmacology of this supplement and its proposed mechanism of injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20358712     DOI: 10.7205/milmed-d-09-00104

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

2.  Emerging supplements in sports.

Authors:  Bryan C Mason; Mark E Lavallee
Journal:  Sports Health       Date:  2012-03       Impact factor: 3.843

3.  Self-reported side-effects associated with use of dietary supplements in an armed forces population.

Authors:  Krista G Austin; Emily K Farina; Harris R Lieberman
Journal:  Drug Test Anal       Date:  2015-11-02       Impact factor: 3.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.